{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:04Z","timestamp":1791215464422,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijid.2026.108962","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:19:06Z","timestamp":1783178346000},"page":"108962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["When institutional transitions interrupt prevention: 3HP tuberculosis preventive treatment continuity in a Paraguayan prison cohort"],"prefix":"10.1016","volume":"170","author":[{"given":"Gladys","family":"Estigarribia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Sequera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"M\u00e9ndez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Santacruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Mendieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-7036","authenticated-orcid":false,"given":"Julio","family":"Torales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108962_sbref0001","series-title":"Tuberculosis data","year":"2025"},{"key":"10.1016\/j.ijid.2026.108962_bib0002","series-title":"WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment","year":"2024"},{"issue":"12","key":"10.1016\/j.ijid.2026.108962_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000381","article-title":"Tuberculosis incidence in prisons: a systematic review","volume":"7","author":"Baussano","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2026.108962_sbref0004","series-title":"Global tuberculosis report 2023","year":"2023"},{"issue":"11","key":"10.1016\/j.ijid.2026.108962_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(24)00192-0","article-title":"Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected effects of policy alternatives: a mathematical modelling study","volume":"9","author":"Liu","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ijid.2026.108962_sbref0006","series-title":"General Directorate of Health Surveillance, National Tuberculosis Control Program. Tuberculosis Epidemiological Report: Paraguay 2023 [Internet]","year":"2025"},{"key":"10.1016\/j.ijid.2026.108962_bib0007","article-title":"Excess tuberculosis risk during and following incarceration in Paraguay: a retrospective cohort study","volume":"31","author":"Sequera","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"23","key":"10.1016\/j.ijid.2026.108962_bib0008","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijid.2026.108962_bib0009","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/cid\/ciad246","article-title":"A systematic review and meta-analysis of tuberculous preventative therapy adverse events","volume":"77","author":"Melnychuk","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108962_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107196","article-title":"Adherence to preventive treatment for latent tuberculosis infection in close contacts of pulmonary tuberculosis patients: a cluster-randomized controlled trial in China","volume":"147","author":"Chen","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108962_bib0011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/QAD.0000000000002380","article-title":"Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV","volume":"34","author":"Kendall","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2026.108962_bib0012","article-title":"Adherence to treatment for tuberculosis infection in children using a comprehensive care strategy: a prospective cohort study with a historical control group","volume":"46","author":"Rodr\u00edguez-M\u00e1rquez","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"7","key":"10.1016\/j.ijid.2026.108962_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001920","article-title":"Community-based tuberculosis contact management: caregiver experience and factors promoting adherence to preventive therapy","volume":"3","author":"Sandoval","year":"2023","journal-title":"PLOS Glob Public Health"},{"issue":"RR\u20139","key":"10.1016\/j.ijid.2026.108962_bib0014","first-page":"1","volume":"55","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ijid.2026.108962_sbref0015","series-title":"Systematic review on the diagnosis, treatment, care and prevention of tuberculosis in prison settings [Internet]. Stockholm","year":"2017"},{"key":"10.1016\/j.ijid.2026.108962_sbref0016","series-title":"General Directorate of Health Surveillance, National Tuberculosis Control Program. National Guidelines for Tuberculosis Management [Internet]. 16a ed","year":"2025"},{"issue":"3","key":"10.1016\/j.ijid.2026.108962_bib0017","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02753-2021","article-title":"Global reporting on tuberculosis preventive treatment among contacts","volume":"59","author":"Falzon","year":"2022","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2026.108962_bib0018","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.ijid.2023.02.016","article-title":"Programmatic management of tuberculosis preventive therapy: past, present, future","volume":"130","author":"Matteelli","year":"2023","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2026.108962_bib0019","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","article-title":"Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid","volume":"169","author":"Villarino","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.ijid.2026.108962_bib0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amepre.2018.04.030","article-title":"Isoniazid-Rifapentine for latent tuberculosis infection: a systematic review and meta-analysis","volume":"55","author":"Njie","year":"2018","journal-title":"Am J Prev Med"},{"issue":"10","key":"10.1016\/j.ijid.2026.108962_bib0021","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial","volume":"167","author":"Belknap","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ijid.2026.108962_bib0022","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(23)00096-6","article-title":"Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis","volume":"11","author":"Winters","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.ijid.2026.108962_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102917","article-title":"Adherence to tuberculosis infection treatment and its impact on prevention of tuberculosis reactivation: a retrospective cohort study from Taiwan","volume":"18","author":"Chien","year":"2025","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijid.2026.108962_sbref0024","series-title":"NTCA provider guidance: using the isoniazid\/rifapentine regimen to treat latent tuberculosis infection (LTBI) [Internet]. Atlanta","year":"2018"},{"issue":"6","key":"10.1016\/j.ijid.2026.108962_bib0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cmi.2023.02.016","article-title":"Treatment of latent tuberculosis infection in incarcerated people: a systematic review","volume":"29","author":"Matucci","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"1_suppl","key":"10.1016\/j.ijid.2026.108962_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/0033354919826557","article-title":"Completion rates, adverse effects, and costs of a 3-month and 9-month treatment regimen for latent tuberculosis infection in California inmates, 2011-2014","volume":"134","author":"Wheeler","year":"2019","journal-title":"Public Health Rep"},{"issue":"1","key":"10.1016\/j.ijid.2026.108962_bib0027","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses","volume":"17","author":"Pease","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2026.108962_bib0028","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COH.0000000000000505","article-title":"Coordinating the prevention, treatment, and care continuum for HIV-associated tuberculosis in prisons: a health systems strengthening approach","volume":"13","author":"Herce","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"10.1016\/j.ijid.2026.108962_bib0029","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1186\/s12879-025-11503-3","article-title":"The impact of digital adherence technologies on treatment outcomes, adherence, and patient-reported outcomes in tuberculosis: a systematic review and meta-analysis","volume":"25","author":"Mohamed","year":"2025","journal-title":"BMC Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:53:39Z","timestamp":1791212019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226005977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S1201971226005977"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108962","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When institutional transitions interrupt prevention: 3HP tuberculosis preventive treatment continuity in a Paraguayan prison cohort","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108962"}}